Article

The AAA+ ATPase RavA and its binding partner ViaA modulate E. coli aminoglycoside…

medRxiv · 2022 · Felix, J.; Bumba, L.; Liesche, C.; Fraudeau, A.; Rebeille, F.; El Khoury, J.; Huard, K.; Gallet, B.; Moriscot, C.; Kleman, J.-P.; Duhoo, Y.; Jessop, M.; Kandiah, E.; Barras, F.; Jouhet, J.; Gutsche, I.

Key facts

Title The AAA+ ATPase RavA and its binding partner ViaA modulate E. coli aminoglycoside sensitivity through interaction with the inner membrane
First author Felix, J.; Bumba, L.; Liesche, C.; Fraudeau, A.; Rebeille, F.; El Khoury, J.; Huard, K.; Gallet, B.; Moriscot, C.; Kleman, J.-P.; Duhoo, Y.; Jessop, M.; Kandiah, E.; Barras, F.; Jouhet, J.; Gutsche, I.
Journal medRxiv
Published Feb 6, 2022
DOI 10.1101/2022.02.06.479298
Devices mentioned K042152, K761172, K761173, K790117, K790769, K802356, K822496, K860751, K940422, K982100
Product codes mentioned CFN, DFZ, GGP, JIT, JOZ, JPA, JPK, JXR

At a glance

  • 10–99 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature